title: Monoclonal antibody therapy and non-Hodgkin's lymphoma.
authors.forename: Mark R
authors.initials: MR
authors.lastname: Goldstein
authors.forename: Luca
authors.initials: L
authors.lastname: Mascitelli
authors.forename: Francesca
authors.initials: F
authors.lastname: Pezzetta
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000187:drug effects / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D008875:Middle Aged; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000069283:Rituximab